BNET Industries
BioScrip Inc. (BIOS) is in the Retail Industry
- Revenue
- Dec 31 2007
- $1.1B
- Profit
- Dec 31 2007
- $3.3M
- Market Cap
- Aug 27 2008
- $157.0M
Latest News and Analysis
BioScrip, Inc. Q2 2008 Earnings Call Transcript
BioScrip, Inc. BIOS Q2 2008 Earnings Call Transcript
BioScrip's Inept Management Continues to Blunder
Amit Chokshi submits: When I first started writing about BioScrip Inc. BIOS I received some encouragement from a variety of shareholders, including both individual and institutional investors who had been disappointed in management's continued incompetence. I also attracted the attention of private specialty pharmacy operators and former employees, which further...
BioScrip, Inc. Q4 2007 Earnings Call Transcript
BioScrip, Inc. Q4 2007 Earnings Call Transcript
Additional Resources
BioScrip to Present at the Noble Financial Equity Conference
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the Fourth Annual Noble Financial Equity Conference, to be held August 18-19, 2008, at the Loews Lake Las Vegas Resort, Nevada. BioScrip's Chairman and CEO, Richard H. Friedman, and Stanley G. Rosenbaum, Executive Vice...
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: AGIX, APKT, BIOS, NOVA, CNXT, CHRD
DALLAS, Aug. 1 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://beaconequity.com/m Today's Trade Alerts include: Atherogenics Inc. , Acme Packet Inc. , BioScrip Inc. ,...
BioScrip, Inc. Reports 2008 Second Quarter Earnings
--Revenues of $348.4 Million; EPS of $0.04; Specialty Services Up 25.3%-- ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today reported net income for the quarter ended June 30, 2008 of $1.6 million, or $0.04 per diluted share, on revenues of $348.4 million, compared to $0.5 million, or $0.01...
BioScrip, Inc. Reports First Quarter Revenues of $328 Million - Loss of $0.01; Specialty Services Revenue up 18%
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today reported first quarter 2008 revenues of $327.5 million compared to first quarter 2007 revenues of $296.2 million. First quarter 2008 EBITDAO (earnings before interest, taxes, depreciation, amortization and option expense) was $2.7 million, operating profit was $185,000 and net loss was $0.5...
BioScrip to Report First Quarter 2008 Earnings on May 2nd
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) announced today that it will host a conference call at 10:00 a.m. ET on May 2, 2008, to discuss its first quarter operating results for the period ended March 31, 2008. BioScrip will issue a press release announcing the operating results before the...
BioScrip Holds Annual Meeting; Re-Affirms Focus on Specialty Services
ELMSFORD, N.Y. -- In remarks at its annual stockholders' meeting, Chairman and Chief Executive Officer, Richard H. Friedman outlined BioScrip's (Nasdaq: BIOS) 2008 key goals and objectives as well as its growth initiatives. At that meeting, Mr. Friedman stated that "By all accounts, BioScrip had a successful year as indicated...
Nacel Energy (OTC BB:NCEN) to Supply Wind Energy to Thousands of Americans.
M2 PRESSWIRE-6 March 2008-WallStreetAnalystReport.com: Nacel Energy (OTC BB:NCEN) to Supply Wind Energy to Thousands of AmericansC1994-2008 M2 COMMUNICATIONS LTD RDATE:06032008 Stocks to Watch: NACEL Energy Corporation (OTC BB:NCEN) , Aspen Exploration Corporation (OTC BB:ASPN), BioScrip Inc (Nasdaq:BIOS) , ...
Has added BioScrip Inc. to their watch list.
M2 PRESSWIRE-5 March 2008-The Maybach Financial Group: Has added BioScrip Inc. to their watch listC1994-2008 M2 COMMUNICATIONS LTD RDATE:05032008 Maybach Financial is a syndicate of financial informants representing a true investing experience. Taking research from financial consultants, brokers, researchers,...
Fourth Quarter and Year end Results Reported for BioScrip, Inc.
M2 PRESSWIRE-5 March 2008-investorIM: Fourth Quarter and Year end Results Reported for BioScrip, Inc.C1994-2008 M2 COMMUNICATIONS LTD RDATE:05032008 InvestorIM has been created as a tool for the average investor. The idea is simple, a website where the world can communicate....
BioScrip, Inc. Reports EPS of $0.06 for Fourth Quarter 2007; EPS of $0.09 for 2007; Twelve Months' Operating Income Improves by $25.1 Million
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today reported fourth quarter 2007 net income of $2.5 million, or $0.06 per diluted share, on revenues of $309.2 million. Fourth quarter EBITDAO (earnings before interest, taxes, depreciation, amortization and option expense) was $5.9 million. Full year 2007 net income was $3.3 million...
BioScrip to Report Fourth Quarter and Year End 2007 Earnings on March 4th
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) announced today that it will host a conference call at 10:00 a.m. ET on March 4, 2008, to discuss its fourth quarter and year end operating results for the period ended December 31, 2007. BioScrip will issue a press release announcing the operating...
BioScrip Responds to CAP Inquiries
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS), a specialty pharmaceutical healthcare organization, today responded to inquiries regarding CAP Medicare Part B Competitive Acquisition Program 2008 enrollment figures. BioScrip reported that utilizing physicians have increased over the last six months. While CMS has reported an approximately 1,000 physician decrease in CAP...
Healthcare News Update.
M2 PRESSWIRE-5 February 2008-Businessnewsnow.us: Healthcare News UpdateC1994-2008 M2 COMMUNICATIONS LTD RDATE:05022008 New York, NY -- HealthSonix, Inc. (OTC: HSXI); Bio-Imaging Technologies, Inc. (NASDAQ: BITI); Arcadia Resources, Inc. (AMEX: KAD); MedAssets, Inc. (NASDAQ: MDAS); BioScrip, Inc. (NASDAQ: BIOS); Progress ...
BioScrip to Present at the UBS Global Healthcare Services Conference
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS), a specialty pharmaceutical health care organization, today announced that it will present at the UBS Global Healthcare Services Conference on February 11, 2008 at the Grand Hyatt New York City. BioScrip's Chairman and CEO, Richard Friedman, and Executive Vice President, CFO...
BioScrip, Inc. Press Release
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS), a comprehensive pharmaceutical care solutions company, today announced that on January 24, 2008, it received written notification from the Nasdaq Listing Qualifications Department ("Nasdaq") that it had violated the shareholder approval requirement set forth in Nasdaq Marketplace Rule 4350i; the notice also indicated...
BioScrip, Inc. Announces Opening of Two New Specialty Pharmacies
ELMSFORD, N.Y. -- BioScrip, Inc. (Nasdaq: BIOS) today announced the opening of new specialty pharmacies in Hawthorne, New York, and Pompano Beach, Florida. The New York location, situated on the campus of Westchester Medical Center, will offer convenient access to specialty and traditional medications to the more than...
BioScrip to Present at 19th Annual Piper Jaffray Health Care Conference
ELMSFORD, N.Y. -- BioScrip, Inc. (NASDAQ:BIOS), a specialty pharmaceutical health care organization today announced that it will present at the 19th Annual Piper Jaffray Health Care Conference on November 27 at The Pierre Hotel in New York, New York. BioScrip's Chairman and CEO, Richard Friedman,...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View by Content TypeClose
- Incorporated: 1996
- CEO: Mr. Richard H. Friedman
- Employees: 874
BioScrip is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management services. Co.'s specialty pharmaceutical services include the support, dispensing and distribution, patient care management, data reporting and a range of other management services for certain medications. Co.'s pharmacy benefit management services include pharmacy network management, claims processing, benefit design, drug utilization review, formulary management and traditional mail order pharmacy fulfillment.
BioScrip Inc. Company Info
Board of Directors
Mr. Richard H. Friedman
Chairman
Mr. Martin Kooper
Ms. Charlotte W. Collins Esquire
Dr. Louis T. DiFazio Ph.D.
Mr. Myron Z. Holubiak
Mr. David R. Hubers
Mr. Richard L. Robbins
Mr. Stuart A. Samuels
Mr. Steven K. Schelhammer
Contact Information
100 Clearbrook Road
Elmsford, NY
914 460-1600
